Delivery Order SPE2DB24D2101-SPE2DB26FKFBR
- Not listed
- The Defense Logistics Agency awarded a $4,817.35 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for AVEED 750 mg/3 mL vials. This competitively awarded contract, with an ultimate completion date of August 27, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a $23,123.28 delivery order by the Defense Logistics Agency's Medical Supply Chain on September 24, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract represents a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of October 16, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $34,684.92 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 5, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract, valued at $23,123.28, carries a firm fixed price and requires completion by June 23, 2025. This is a non-set-aside delivery order issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order valued at $5,780.82 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on September 23, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contractor's place of performance is located in Conshohocken, Pennsylvania, the company's headquarters...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,452.05 by the Defense Logistics Agency on September 15, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract utilizes firm fixed price pricing and is scheduled for completion by October 6, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order has a ceiling value of $96,347.00 and a completion date of May 30, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which also serves as the place of performance—is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The order carries a ceiling value of $34,684.92 and is structured as a firm fixed-price delivery order with an ultimate completion date of June 23, 2025. This is a non-set-aside contract awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,853.88 for AVEED 750 mg/3 mL vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy indicated for treating low...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $7,765.20 contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML pharmaceutical products. The delivery order was issued under an indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB26FKFBRDelivery Order
The Defense Logistics Agency awarded a $1,926.94 delivery order to AmerisourceBergen Drug Corp for AVEED 750 mg/3 ml vials on October 22, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle that enables supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for AVEED, a testosterone replacement therapy, exemplifies the routine pharmaceutical procurement executed under the broader contract vehicle that positions AmerisourceBergen as a primary source for DoD medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/22/25 |